Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Claxton

Showing results (11-20 of 45) with videos related to

Pageof 5
Sort By:
International Journal of Molecular Sciences|January 23, 2024
Clofarabine Preconditioning followed by Allogeneic Transplant Using TBI and Post-Transplant Cyclophosphamide for Relapsed Refractory LeukemiaSeema Naik, Kevin Rakszawski, Hong Zheng, et al.
International Journal of Hematology|March 16, 2018
Clofarabine followed by haploidentical stem cell transplant using fludarabine, busulfan, and total-body irradiation with post-transplant cyclophosphamide in non-remission AMLKevin Rakszawski, Kosuke Miki, David Claxton, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|April 16, 2009
Hypercoagulable states in patients with multiple myeloma can affect the thalidomide-associated venous thromboembolismGiampaolo P Talamo, Sulfi Ibrahim, David Claxton, et al.
Cancers|October 26, 2024
From Deworming to Cancer Therapy: Benzimidazoles in Hematological MalignanciesUpendarrao Golla, Satyam Patel, Nyah Shah, et al.
Cancer Biology & Therapy|May 21, 2014
Maritoclax induces apoptosis in acute myeloid leukemia cells with elevated Mcl-1 expressionKenichiro Doi, Qiang Liu, Krishne Gowda, et al.
Human Pathology|August 28, 2002
T-cell blast crisis of chronic myelogenous leukemia manifesting as a large mediastinal tumorCharles C Ye, Carolina Echeverri, Jeanne E Anderson, et al.
International Journal of Molecular Sciences|July 27, 2022
Therapeutic Benefits of Selenium in Hematological MalignanciesMelanie A Ehudin, Upendarrao Golla, Devnah Trivedi, et al.
Plos One|October 7, 2014
A multicenter phase I/II study of obatoclax mesylate administered as a 3- or 24-hour infusion in older patients with previously untreated acute myeloid leukemiaAaron D Schimmer, Azra Raza, Thomas H Carter, et al.
Leukemia & Lymphoma|September 1, 2011
Outpatient consolidation treatment with clofarabine in a phase 2 study of older adult patients with previously untreated acute myelogenous leukemiaDavid Claxton, Harry P Erba, Stefan Faderl, et al.
Cancer Biology & Therapy|December 24, 2014
Pyoluteorin derivatives induce Mcl-1 degradation and apoptosis in hematological cancer cellsKenichiro Doi, Krishne Gowda, Qiang Liu, et al.
Pageof 5

Showing results (11-20 of 45) with videos related to

Sort By:
Pageof 5
International Journal of Molecular Sciences|January 23, 2024
Clofarabine Preconditioning followed by Allogeneic Transplant Using TBI and Post-Transplant Cyclophosphamide for Relapsed Refractory LeukemiaSeema Naik, Kevin Rakszawski, Hong Zheng, et al.
International Journal of Hematology|March 16, 2018
Clofarabine followed by haploidentical stem cell transplant using fludarabine, busulfan, and total-body irradiation with post-transplant cyclophosphamide in non-remission AMLKevin Rakszawski, Kosuke Miki, David Claxton, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|April 16, 2009
Hypercoagulable states in patients with multiple myeloma can affect the thalidomide-associated venous thromboembolismGiampaolo P Talamo, Sulfi Ibrahim, David Claxton, et al.
Cancers|October 26, 2024
From Deworming to Cancer Therapy: Benzimidazoles in Hematological MalignanciesUpendarrao Golla, Satyam Patel, Nyah Shah, et al.
Cancer Biology & Therapy|May 21, 2014
Maritoclax induces apoptosis in acute myeloid leukemia cells with elevated Mcl-1 expressionKenichiro Doi, Qiang Liu, Krishne Gowda, et al.
Human Pathology|August 28, 2002
T-cell blast crisis of chronic myelogenous leukemia manifesting as a large mediastinal tumorCharles C Ye, Carolina Echeverri, Jeanne E Anderson, et al.
International Journal of Molecular Sciences|July 27, 2022
Therapeutic Benefits of Selenium in Hematological MalignanciesMelanie A Ehudin, Upendarrao Golla, Devnah Trivedi, et al.
Plos One|October 7, 2014
A multicenter phase I/II study of obatoclax mesylate administered as a 3- or 24-hour infusion in older patients with previously untreated acute myeloid leukemiaAaron D Schimmer, Azra Raza, Thomas H Carter, et al.
Leukemia & Lymphoma|September 1, 2011
Outpatient consolidation treatment with clofarabine in a phase 2 study of older adult patients with previously untreated acute myelogenous leukemiaDavid Claxton, Harry P Erba, Stefan Faderl, et al.
Cancer Biology & Therapy|December 24, 2014
Pyoluteorin derivatives induce Mcl-1 degradation and apoptosis in hematological cancer cellsKenichiro Doi, Krishne Gowda, Qiang Liu, et al.
Pageof 5